Treatment of congestion in upper respiratory diseases
Eli O Meltzer1, Fernan Caballero2, Leonard M Fromer3, John H Krouse4, Glenis Scadding51Allergy and Asthma Medical Group and Research Center, San Diego, CA and Department of Pediatrics, University of California, San Diego, USA; 2Allergy and Clinical ...
Eli O Meltzer +3 more
doaj
Real-world effectiveness of fluticasone propionate-azelastine nasal spray in moderate-to-severe nonallergic and perennial allergic rhinitis. [PDF]
Chokevittaya P +15 more
europepmc +1 more source
Toward personalized prediction: a multicenter machine learning model for omalizumab response duration in moderate-to-severe perennial allergic rhinitis. [PDF]
Miao Z +7 more
europepmc +1 more source
Clinical Efficacy and Safety of Low-Level Laser Therapy in Patients with Perennial Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Trial. [PDF]
Jung HJ +4 more
europepmc +1 more source
A Survey on Seasonal Symptoms in Subjects with and Without Allergic Rhinitis Diagnosis
In Switzerland, only scarce data are available on the prevalence and treatment of allergic rhinitis. Although the presence of AR symptoms in temporal relation to the respective aeroallergen is indicative, still a substantial number of affected ...
Victor Colin +6 more
core +1 more source
In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate. [PDF]
Bousquet J +6 more
europepmc +1 more source
Evaluating the impact of acupuncture on perennial allergic rhinitis: A randomized placebo acupuncture control trial protocol. [PDF]
Meng C +11 more
europepmc +1 more source
Low serum 25-hydroxyvitamin D levels are associated with perennial allergic rhinitis but not disease severity. [PDF]
Ma Y, Liu Y, Li X, Qiu J, Fang P.
europepmc +1 more source
Disease burden in children with moderate to severe perennial allergic rhinitis and concomitant asthma in Canada, Denmark, and the United Kingdom. [PDF]
Vahlkvist SV +7 more
europepmc +1 more source
Prospective, Single-Arm, Investigator-Initiated Study to Evaluate Efficacy and Safety of Levocetirizine Hydrochloride 5 mg and Montelukast 10 mg (L-Montus) in Patients With Seasonal Allergic Rhinitis and Perennial Allergic Rhinitis. [PDF]
Ramappa C +6 more
europepmc +1 more source

